Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation Factors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140051839A1
SERIAL NO

13885612

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A process for reduction and/or removal of FXI and FXIa from a source solution containing said coagulation factors and as main components immunoglobulins comprising the following steps:

    a) contacting the FXI and/or FXIa containing solution with an affinity chromatographic gel wherein heparin or heparan is linked to the matrix material;b) allowing adsorption of FXI and/or FXIa andc) separation of the liquid deprived of FXI and/or FXIa from the adsorption media.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OCTAPHARMA AG8853 LACHEN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bal, Frederic Lingolsheim, FR 3 14
Gruber, Gerhard Vienna, AT 18 144
Marks, Frank Springe, DE 11 24
Schultz, Petra VIENNA, AT 1 0
Winge, Stefan Stockholm, SE 26 146

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation